(MedPage Today) -- The FDA has approved the angiogenesis inhibitor ramucirumab (Cyramza) for treatment of advanced gastric cancer or adenocarcinoma of the gastroesophageal junction. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment